Area of research
Epidemiology · Reproductive Medicine
Research interest
Research interests include Cervical Cancer and HPV Research, Ovarian cancer diagnosis and treatment, Endometrial and Cervical Cancer Treatments, and Reproductive tract infections research.
453 Senaparib maintenance in newly diagnosed advanced ovarian cancer: FLAMES study
LBA36 Efficacy and safety of senaparib as maintenance treatment in patients with newly diagnosed advanced ovarian cancer (FLAMES study): A randomized, double-blind, placebo-controlled, phase III trial
[Evaluation of the efficacy and safety of Nocardia rubra cell wall skeleton immunotherapy for cervical high-risk HPV persistent infection].
765P SABRINA study: A phase II study of senaparib monotherapy for patients (pts) with BRCA1/2 mutated recurrent platinum-sensitive ovarian cancer (PSOC)
Fuzuloparib Maintenance Therapy in Patients With Platinum-Sensitive, Recurrent Ovarian Carcinoma (FZOCUS-2): A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Trial
Pamiparib Monotherapy for Patients with Germline <i>BRCA1/2</i> -Mutated Ovarian Cancer Previously Treated with at Least Two Lines of Chemotherapy: A Multicenter, Open-Label, Phase II Study
High Expression of MYL9 Indicates Poor Clinical Prognosis of Epithelial Ovarian Cancer
820P Phase II study of pamiparib in Chinese patients (pts) with advanced ovarian cancer (aOC)
Downregulation of long noncoding RNA MEG3 is associated with poor prognosis and promoter hypermethylation in cervical cancer
Aberrant Methylation of MEG3 Functions as a Potential Plasma-Based Biomarker for Cervical Cancer